Alpha Tau Medical Ltd. (DRTS)
14.51
-0.33
(-2.22%)
USD |
NASDAQ |
Sep 09, 10:31
Alpha Tau Medical Max Drawdown (5Y) : 86.86% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 86.86% |
| July 31, 2026 | 86.86% |
| June 30, 2026 | 86.86% |
| May 31, 2026 | 86.86% |
| April 30, 2026 | 86.86% |
| March 31, 2026 | 86.86% |
| February 28, 2026 | 86.86% |
| January 31, 2026 | 86.86% |
| December 31, 2025 | 86.86% |
| Date | Value |
|---|---|
| November 30, 2025 | 86.86% |
| October 31, 2025 | 86.86% |
| September 30, 2025 | 86.86% |
| August 31, 2025 | 86.86% |
| July 31, 2025 | 86.86% |
| June 30, 2025 | 86.86% |
| May 31, 2025 | 86.86% |
| April 30, 2025 | 86.86% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Odysight.ai, Inc. | 90.67% |
| Co-Diagnostics, Inc. | 99.67% |
| Ondine Biomedical, Inc. | -- |
| Fractyl Health, Inc. | -- |
| Polyrizon Ltd. | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -7.155 |
| Beta (5Y) | 1.200 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 65.58% |
| Historical Sharpe Ratio (5Y) | 0.0569 |
| Historical Sortino (5Y) | 0.1041 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 24.88% |